NGL Fine-Chem Ltd.

NGLFINE Share PricePharmaceuticals & Drugs

1,326.7

7.4 (0.6%)

As on December 12, 2025

Exchange Scrips: BSE524774NSENGLFINEISININE887E01022

Market Cap819 Cr

P/E Ratio 39.25

Dividend Yield 0.03 %

Performance

Market performance

Open1,314.8
High1,339.8
Volumes3,784
Prev1,326.7
Low1,300.1
As on2025-12-12

Historical performance

1 Year High2,077.45
3 Year High2,823.9
5 Year High2,823.9
1 Year Low957
3 Year Low957
5 Year Low957

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
819
Face Value
Face Value (₹)
5
P/E Ratio
P/E Ratio
39.25
Dividend Yield
Dividend Yield
0.03 %

Investment Returns

1 Year
-30%
3 Years
-20%
5 Years
N/A
10 Years
N/A

Technicals

IndicatorsValueSignal
5-DMA1,309.66Bullish
10-DMA1,314.12Bullish
20-DMA1,332.36Bearish
50-DMA1,429.55Bearish
100-DMA1,399.61Bearish
200-DMA1,267.69Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters55555
Foreign Investors---------------
Domestic Investors55555
Public Investors1338214005143811410514570
Government---------------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 39.25.
  • 3Y Stock Price CAGR of the stock is -6.6.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹434 Million.
  • The company generated revenue of ₹3683 Million in the previous financial year.

NGL Fine-Chem Ltd.

1326.77.4   (0.6%)

Investment Amount: ₹ 1000000
Current Value: ₹ 691097.6
No. of Shares: 521 (Approx)
Performance:-30.9%
P/L: ₹-308902.4

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month